Genomics
Obtain access to our extensive collection of pharmacogenomic research. Our library of research encompasses various areas of genetic engineering research such as cutting-edge fields comprising of gene cloning, bacterial genomes sequencing and transgenic research.
Additional research regarding human genome research is also included offering extensive information on genome analysis. More specific studies are featured regarding fetal genetic testing, genetic diseases, and genomic analysis.
Regardless of which field of genomics market research you specialize in, Marketsensus provides you with an extensive library of up-to-date and complete molecular genetics and genomics research, enabling informed decision making.
-
Molybdenum-99: Privatising Nuclear Medicine
Date of report : Oct 6, 2011$530.00This Special Report from Business Monitor International (BMI) examines the global supply of Molybdenum- 99, looking at the likelihood of price rises and the implications of investment. The report is split into the following topics: • Molybdenum-99, The Birth Of A New Commodity • The Demand For... Learn More -
Generics: Global Industry Guide
Date of report : Jun 20, 2011$995.00Datamonitor's Generics Global Industry Guide is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This i... Learn More -
Stem Cell Market: Opportunities and Challenges
Date of report : Jan 12, 2010$800.00Stem cell biology is a promising and emerging field of the life sciences. Advances in biological sciences and the development of human stem cells are bringing new hope for the treatment of many diseases such as Parkinson’s disease, diabetes, heart diseases and cancer as well as injuries for which ... Learn More -
The Future of Monoclonal Antibodies Therapeutics: Innovation in antibody engineering, key growth strategies and forecasts to 2011
Date of report : Dec 7, 2006$2,875.00The monoclonal antibody (mAb) market has grown rapidly in recent years, reaching sales of $14bn in 2005, an increase of 36.5% from 2004 sales of $10.3bn. Köhler and Milstein developed the hybridoma method of murine antibody production in 1975, which allowed the production of the first mAb to market... Learn More -
The Future of Metabolomics: Building competitive advantage in drug discovery, clinical development and diagnostics
Date of report : Aug 16, 2006$2,875.00Metabolomics - the new ‘omics’ - is a dynamic and emerging field, joining genomics, transcriptomics and proteomics in enabling an integrative systems biology approach to drug discovery and development. Although metabolomics is still at an early evolutionary stage it is forecast that over the nex... Learn More
Loading...